Lunai Bioworks Inc.
NASDAQ: LNAI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- David H. Weinstein
- Employees
- 29
- Headquarters
- Los Angeles, United States
- IPO year
- 2025
- Market cap
- $15.6M
- Website
- http://www.renovarogroup.com
Loading LNAI…
Loading profile data…Frequently asked questions about LNAI
What does Lunai Bioworks Inc. (LNAI) do?
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."
Where does LNAI trade?
Lunai Bioworks Inc. (LNAI) trades on the NASDAQ Global Market.
What sector is LNAI in?
Lunai Bioworks Inc. (LNAI) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Lunai Bioworks Inc.?
David H. Weinstein is the chief executive officer of Lunai Bioworks Inc. (LNAI).
Where is Lunai Bioworks Inc. headquartered?
Lunai Bioworks Inc. is headquartered in United States.
Does LNAI pay a dividend?
Lunai Bioworks Inc. (LNAI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LNAI go public?
Lunai Bioworks Inc. (LNAI) completed its initial public offering in 2025.